This article will detail the
relative effectiveness of warnings issued by the FDA regarding Urogynecologic
mesh use. According to the article, An
Appraisal of the Food and Drug Administration Warning on Urogynecologic
Surgical Mesh, published in Current Urology Reports (2012, 13:231-239)
manufacturers market surgical mesh kits with a goal of increasing speed and
ease of placement. The FDA reports over the past few years have sought to increase
the awareness of the potential risks of surgical mesh when used in a
transvaginal surgical procedure despite manufacturer’s claims.
More and more often reports
are coming out which emphasize the fact that surgeons who use these mesh kits must have specialized training which
enables them to “recognize and manage the
complications of surgical mesh implants.” Governmental regulation of these
mesh devices has also come under fire; while there are many different agencies
in charge of regulation and reporting, women have nevertheless been harmed by transvaginally
placed mesh implants.
